Back to Search Start Over

Systematic transcriptomic analysis of childhood medulloblastoma identifies N6-methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosis.

Authors :
Joshi, Kandarp
Yuan, Menglang
Katsushima, Keisuke
Saulnier, Olivier
Ray, Animesh
Amankwah, Ernest
Stapleton, Stacie
Jallo, George
Taylor, Michael D.
Eberhart, Charles G.
Perera, Ranjan J.
Source :
Acta Neuropathologica Communications; 8/28/2024, Vol. 12 Issue 1, p1-14, 14p
Publication Year :
2024

Abstract

Medulloblastoma, the most common malignant pediatric brain tumor, is classified into four main molecular subgroups, but group 3 and group 4 tumors are difficult to subclassify and have a poor prognosis. Rapid point-of-care diagnostic and prognostic assays are needed to improve medulloblastoma risk stratification and management. N6-methyladenosine (m6A) is a common RNA modification and long non-coding RNAs (lncRNAs) play a central role in tumor progression, but their impact on gene expression and associated clinical outcomes in medulloblastoma are unknown. Here we analyzed 469 medulloblastoma tumor transcriptomes to identify lncRNAs co-expressed with m6A regulators. Using LASSO-Cox analysis, we identified a five-gene m6A-associated lncRNA signature (M6LSig) significantly associated with overall survival, which was combined in a prognostic clinical nomogram. Using expression of the 67 m6A-associated lncRNAs, a subgroup classification model was generated using the XGBoost machine learning algorithm, which had a classification accuracy > 90%, including for group 3 and 4 samples. All M6LSig genes were significantly correlated with at least one immune cell type abundance in the tumor microenvironment, and the risk score was positively correlated with CD4<superscript>+</superscript> naïve T cell abundance and negatively correlated with follicular helper T cells and eosinophils. Knockdown of key m6A writer genes METTL3 and METTL14 in a group 3 medulloblastoma cell line (D425-Med) decreased cell proliferation and upregulated many M6LSig genes identified in our in silico analysis, suggesting that the signature genes are functional in medulloblastoma. This study highlights a crucial role for m6A-dependent lncRNAs in medulloblastoma prognosis and immune responses and provides the foundation for practical clinical tools that can be rapidly deployed in clinical settings. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20515960
Volume :
12
Issue :
1
Database :
Complementary Index
Journal :
Acta Neuropathologica Communications
Publication Type :
Academic Journal
Accession number :
179295228
Full Text :
https://doi.org/10.1186/s40478-024-01848-2